Hikma Pharmaceuticals PLC (LSE:HIK)
£ 19.58 -0.01 (-0.05%) Market Cap: 4.34 Bil Enterprise Value: 5.10 Bil PE Ratio: 29.14 PB Ratio: 2.49 GF Score: 92/100

Half Year 2022 Hikma Pharmaceuticals PLC Earnings Pre-Recorded Presentation Transcript

Aug 04, 2022 / 06:00AM GMT
Release Date Price: £16.51 (-6.33%)
Said Samih Taleb Darwazah
Hikma Pharmaceuticals PLC - Executive Chairman & CEO

Presentation
Aug 04, 2022 / 06:00AM GMT

=====================
Corporate Participants
=====================
* Khalid Waleed Hosny Al Nabilsi
Hikma Pharmaceuticals PLC - CFO
* Said Samih Taleb Darwazah
Hikma Pharmaceuticals PLC - Executive Chairman & CEO

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot